Company · CIK 0001398161
Targanta Therapeutics Corp.
Exchange
—
Entity type
operating
Fiscal year end
Dec 31
Headquarters
DE
Search this company’s filings
Search features10 guest searches · Free accounts get 10 a day · No credit card
On the record
Recent filings
- SC 13G/ATarganta Therapeutics Corp.0001172661-09-000619 · 12.3 KBSEC(opens sec.gov)
- 8-K/ATarganta Therapeutics Corp.0000950123-09-004209 · 12.0 KBSEC(opens sec.gov)
- 8-KCurrent report0000950123-09-003858 · 187.2 KBSEC(opens sec.gov)
- SC 13G/ATarganta Therapeutics Corp.0001193125-09-031113 · 61.4 KBSEC(opens sec.gov)
- 8-KCurrent report0000950123-09-000666 · 538.0 KBSEC(opens sec.gov)
- 8-KCurrent report0001193125-08-183968 · 34.7 KBSEC(opens sec.gov)
- SC 13GTarganta Therapeutics Corp.0001193125-08-096601 · 168.9 KBSEC(opens sec.gov)
- 8-KCurrent report0001193125-08-077684 · 33.5 KBSEC(opens sec.gov)
- 8-KCurrent report0001193125-08-001342 · 14.7 KBSEC(opens sec.gov)
- SC 13G/ATarganta Therapeutics Corp.0001193125-08-001151 · 140.6 KBSEC(opens sec.gov)
Insiders
Tickers
No tickers on record.
Addresses
business
222 THIRD AVENUE SUITE 2300
CAMBRIDGE, MA, 02142
mailing
222 THIRD AVENUE SUITE 2300
CAMBRIDGE, MA, 02142
Same industry